SG Americas Securities’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $413K | Sell |
4,302
-22,902
| -84% | -$2.35M | ﹤0.01% | 2435 |
|
|
2026
Q1 | $2.97M | Sell |
27,204
-28,605
| -51% | -$2.73M | ﹤0.01% | 1229 |
|
|
2025
Q4 | $4.53M | Buy |
55,809
+43,230
| +344% | +$3.72M | 0.01% | 1136 |
|
|
2025
Q3 | $1.1M | Buy |
+12,579
| New | +$1.12M | ﹤0.01% | 1372 |
|
|
2025
Q2 | – | Sell |
-2,193
| Closed | -$184K | – | 3301 |
|
|
2025
Q1 | $184K | Buy |
2,193
+480
| +28% | +$44.7K | ﹤0.01% | 2591 |
|
|
2024
Q4 | $158K | Buy |
+1,713
| New | +$165K | ﹤0.01% | 2368 |
|
|
2024
Q3 | – | Sell |
-2,150
| Closed | -$177K | – | 3522 |
|
|
2024
Q2 | $177K | Buy |
+2,150
| New | +$158K | ﹤0.01% | 2232 |
|
|
2023
Q4 | – | Sell |
-16,223
| Closed | -$884K | – | 3288 |
|
|
2023
Q3 | $884K | Buy |
+16,223
| New | +$961K | 0.01% | 1373 |
|
|
2023
Q2 | – | Sell |
-15,359
| Closed | -$791K | – | 2773 |
|
|
2023
Q1 | $791K | Buy |
15,359
+10,736
| +232% | +$521K | 0.01% | 1333 |
|
|
2022
Q4 | $213K | Sell |
4,623
-9,056
| -66% | -$424K | ﹤0.01% | 2148 |
|
|
2022
Q3 | $693K | Sell |
13,679
-11,059
| -45% | -$553K | 0.01% | 1269 |
|
|
2022
Q2 | $1.13M | Buy |
+24,738
| New | +$1.11M | 0.01% | 1200 |
|
|
2022
Q1 | – | Sell |
-5,090
| Closed | -$256K | – | 3238 |
|
|
2021
Q4 | $256K | Sell |
5,090
-15,419
| -75% | -$797K | ﹤0.01% | 2537 |
|
|
2021
Q3 | $1.09M | Buy |
20,509
+18,633
| +993% | +$1.05M | 0.01% | 1842 |
|
|
2021
Q2 | $114K | Sell |
1,876
-1,758
| -48% | -$93.4K | ﹤0.01% | 2588 |
|
|
2021
Q1 | $177K | Buy |
+3,634
| New | +$170K | ﹤0.01% | 2753 |
|
|
2020
Q3 | – | Sell |
-8,598
| Closed | -$227K | – | 3112 |
|
|
2020
Q2 | $227K | Buy |
8,598
+1,234
| +17% | +$32.3K | ﹤0.01% | 2750 |
|
|
2020
Q1 | $184K | Buy |
7,364
+4,157
| +130% | +$128K | ﹤0.01% | 2560 |
|
|
2019
Q4 | $115K | Buy |
+3,207
| New | +$111K | ﹤0.01% | 2870 |
|
|
2019
Q3 | – | Sell |
-5,841
| Closed | -$163K | – | 3123 |
|
|
2019
Q2 | $163K | Sell |
5,841
-4,805
| -45% | -$134K | ﹤0.01% | 2541 |
|
|
2019
Q1 | $330K | Buy |
10,646
+3,502
| +49% | +$93.5K | ﹤0.01% | 2187 |
|
|
2018
Q4 | $169K | Sell |
7,144
-61
| -0.8% | -$1.67K | ﹤0.01% | 2465 |
|
|
2018
Q3 | $279K | Sell |
7,205
-4,577
| -39% | -$165K | ﹤0.01% | 2401 |
|
|
2018
Q2 | $394K | Buy |
+11,782
| New | +$419K | ﹤0.01% | 2175 |
|
|
2017
Q2 | – | Sell |
-14,325
| Closed | -$353K | – | 3366 |
|
|
2017
Q1 | $353K | Buy |
+14,325
| New | +$336K | ﹤0.01% | 2078 |
|
Other funds holding LMAT
CCA
CAM
CCM
SG Americas Securities's LMAT Position: Q2 2026 in Review
SG Americas Securities reduced its LeMaitre Vascular (LMAT) stake by 84% in Q2 2026, selling an estimated $2.35M and leaving 4,302 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.
SG Americas Securities first reported a position in LMAT in Q1 2017 and has held it in 25 quarters since. The position peaked at $4.53M in Q4 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- SG Americas Securities held 4,302 shares of LeMaitre Vascular worth $413K as of Q2 2026.
- SG Americas Securities sold 22,902 LeMaitre Vascular shares in Q2 2026, an estimated $2.35M.
- LeMaitre Vascular made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2435 holding.
- SG Americas Securities first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 25 quarters since.
- SG Americas Securities's LeMaitre Vascular position peaked at $4.53M in Q4 2025.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.